New open access journal: Bone Reports from Elsevier

NewsGuard 100/100 Score

Elsevier, world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access journal: Bone Reports.

As sister publication to the highly reputable journal Bone, Bone Reports will serve as an interdisciplinary forum for the rapid publication of research articles and case reports across basic, translational and clinical aspects of bone and mineral metabolism. The journal welcomes studies replicating or failing to replicate previous studies.

Editor-in-Chief for Bone Reports, Professor Peter R. Ebeling, Monash University, and also Senior Editor for sister journal Bone, commented, "I am excited to serve as Editor-in-Chief of Bone Reports, which fulfils a critical and current need to enhance research by publishing reproducibility studies and null findings."

"I am delighted to partner with Professor Ebeling," said Editor-in-Chief of Bone, Professor Sundeep Khosla, Mayo Clinic, explaining that, "with the launch of Bone Reports authors now have a new option to publish solid science related to bone metabolism. I believe the two journals will complement each other very well and expand the scope of content we can provide to our readers."

Source: http://www.journals.elsevier.com/bone-reports/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advancing osteosarcoma prognosis with AI-assisted tumor cell density analysis